Rentabilidad en 3 años
| Fondo | Fecha | |||||
|---|---|---|---|---|---|---|
| 3 años | ||||||
| Resultados por página: 10 | 20 | 50 | 100Se muestran de 1701 a 1710 de un total de 43556 fondos | ||||||
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | 02/11 | 80,32% | ||||
| JPM US TECHNOLOGY I2 (ACC) EUR (HEDGED) | 02/11 | 80,30% | ||||
| MFS MERIDIAN CONTRARIAN VALUE FUND A1-EUR | 02/11 | 80,26% | ||||
| AMUNDI NASDAQ-100 SWAP UCITS ETF EUR CAP | 02/11 | 80,25% | ||||
| CINVEST MULTIGESTION / CORNAMUSA | 30/10 | 80,25% | ||||
| JPM EUROPE STRATEGIC VALUE D (ACC) EUR | 02/11 | 80,25% | ||||
| AXA WORLD FUNDS-ARTIFICIAL INTELLIGENCE I CAP USD | 02/11 | 80,24% | ||||
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | 02/11 | 80,24% | ||||
| JPM EUROPE STRATEGIC DIVIDEND C (ACC) USD (HEDGED) | 02/11 | 80,22% | ||||
| DWS INVEST CROCI JAPAN USD ICH | 02/11 | 80,18% | ||||
